{"protocolSection":{"identificationModule":{"nctId":"NCT04607486","orgStudyIdInfo":{"id":"S60153"},"organization":{"fullName":"Universitaire Ziekenhuizen KU Leuven","class":"OTHER"},"briefTitle":"Investigation of Changes in Lower Limb Muscles After Cerebrovascular Accident","officialTitle":"Reliability Study of a 3D Free-hand Ultrasonography Technique (3DfUS) in Combination With Instrumented Spasticity Assessment (ISA) for the Lower Limb in Chronic First-ever Stroke Patients."},"statusModule":{"statusVerifiedDate":"2023-04","overallStatus":"RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2018-06-18","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2024-10-31","type":"ESTIMATED"},"completionDateStruct":{"date":"2024-12-30","type":"ESTIMATED"},"studyFirstSubmitDate":"2020-08-06","studyFirstSubmitQcDate":"2020-10-22","studyFirstPostDateStruct":{"date":"2020-10-29","type":"ACTUAL"},"lastUpdateSubmitDate":"2023-04-24","lastUpdatePostDateStruct":{"date":"2023-04-25","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Universitaire Ziekenhuizen KU Leuven","class":"OTHER"}},"oversightModule":{"oversightHasDmc":false,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"The aim of this study is to investigate lower limb muscles after cerebrovascular accident","detailedDescription":"The aim of this study is to define and differentiate the changes in MMT properties related to the alterations in muscle tone of the lower limb in first-ever chronic stroke patients by using a 3D free-hand Ultrasonography (3DfUS) technique in combination with an instrumented spasticity assessment (IPSA). In these chronic stroke patients, the spontaneous neurological recovery is stabilized"},"conditionsModule":{"conditions":["Cerebrovascular Accident"]},"designModule":{"studyType":"OBSERVATIONAL","patientRegistry":true,"targetDuration":"1 Day","designInfo":{"observationalModel":"CASE_CONTROL","timePerspective":"CROSS_SECTIONAL"},"enrollmentInfo":{"count":90,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"CVA and spasticity","description":"Adults with first-ever chronic CVA and leg spasticity","interventionNames":["Diagnostic Test: 3DfUS and IPSA of leg muscles"]},{"label":"CVA without spasticity","description":"Control group","interventionNames":["Diagnostic Test: 3DfUS and IPSA of leg muscles"]},{"label":"healthy subjects","description":"Control group","interventionNames":["Diagnostic Test: 3DfUS and IPSA of leg muscles"]}],"interventions":[{"type":"DIAGNOSTIC_TEST","name":"3DfUS and IPSA of leg muscles","description":"1. 3DfUS technique enhances a conventional 2D US device into a platform capable of reconstructing 3D anatomical data sets.\n2. IPSA for quantification of hyper-resistance and its underlying components. The sensors in the IPSa include gyroscopes and accelerometers to measure joint angle and angular velocity, EMG to measure muscle activity, and a 3 degrees-of freedom force sensor to measure torque applied on the joint.\n3. clinical functional capacity = clinical evaluation of degree of independence, mobility and gait","armGroupLabels":["CVA and spasticity","CVA without spasticity","healthy subjects"],"otherNames":["clinical functional capacity"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Muscle volume","description":"Estimation of muscle volume by 3D freehand ultrasonography.","timeFrame":"1 day"},{"measure":"Muscle and Tendon Length","description":"Estimation of muscle volume by 3D freehand ultrasonography","timeFrame":"1 day"},{"measure":"Echogenicity intensity","description":"Estimation of echogenicity intensity by 3D freehand ultrasonography on an 8-bit greyscale (256 values).","timeFrame":"1 day"},{"measure":"Work [J] derived from the slow stretch","description":"Measurement of Work \\[J\\] by Instrumented Spasticity Assessment","timeFrame":"1 day"},{"measure":"Muscle activity EMG [uV] derived from the fast stretch","description":"Measurement of Muscle activity EMG \\[uV\\] by Instrumented Spasticity Assessment","timeFrame":"1 day"},{"measure":"Maximal velocity of performance (Vmax [deg/s])","description":"Measurement of Maximal velocity of performance (Vmax \\[deg/s\\]) by Instrumented Spasticity Assessment","timeFrame":"1 day"},{"measure":"Range of motion [deg] for slow stretch","description":"Measurement of Range of motion \\[deg\\] by Instrumented Spasticity Assessment","timeFrame":"1 day"},{"measure":"Stiffness [Nm/deg] for slow stretch","description":"Measurement of Stiffness \\[Nm/deg\\] by Instrumented Spasticity Assessment","timeFrame":"1 day"},{"measure":"Joint angle of catch [deg] from the fast stretch","description":"Measurement of Joint angle of catch \\[deg\\] from the fast stretch by Instrumented Spasticity Assessment","timeFrame":"1 day"},{"measure":"Angle of EMG threshold [deg] from the fast stretch","description":"Measurement of Angle of EMG threshold \\[deg\\] by Instrumented Spasticity Assessment","timeFrame":"1 day"},{"measure":"Intensity of catch derived from the fast stretch","description":"Measurement of Intensity of catch by Instrumented Spasticity Assessment","timeFrame":"1 day"}],"secondaryOutcomes":[{"measure":"Clinical assessment of spasticity at fast stretch","description":"Estimation of spasticity by Modified Assessment Scale","timeFrame":"1 day"},{"measure":"Clinical assessment of spasticity angle at slow and fast stretch","description":"Estimation of spasticity by Tardieu Scale","timeFrame":"1 day"}],"otherOutcomes":[{"measure":"Quantify the impairment caused by a stroke","description":"Evaluation of impairment caused by stroke by National Institute Health Stroke Scale","timeFrame":"1 day"},{"measure":"Assessments of functional independence in daily life in stroke patients and healthy subjects","description":"Evaluation of functional independence in daily life is assessed by the Barthel Index","timeFrame":"1 day"},{"measure":"Assessments of functional status after stroke","description":"Evaluation of functional status after stroke is assessed by the Functional Independence Measure","timeFrame":"1 day"},{"measure":"Assessesment of mobility in stroke patients","description":"Evaluation of mobility after stroke is assessed by the Rivermead Mobility Index","timeFrame":"1 day"},{"measure":"Assessment of transfer skills in stroke patients and healthy subjects","description":"Measurement of functional lower extremity strength and/or identify movement strategies in stroke patients and healthy subjects by The Five Times Sit to Stand Test","timeFrame":"1 day"},{"measure":"Assessment of the motor impairment in lower limbs of stroke patients","description":"Measurement of lower limb strength in stroke patients by the Motricity Index","timeFrame":"1 day"},{"measure":"Assessments of gait speed analysis in stroke patients and healthy subjects.","description":"1 day","timeFrame":"Measurement of gait speed in stroke patients and healthy subjects by 5-Meter Walk Test at comfortable or self-selected gait speed."}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Definition of case population :\n\n  o first ever stroke with spasticity of the lower limb.\n* Definition of control :\n\n  * first ever stroke without spasticity of the lower limb\n  * healthy aged-matched subjects\n\nExclusion Criteria:\n\n* Musculoskeletal or neurological problems affecting the lower limb\n* Presence of other neurological pathology that could lead to spasticity, ataxia, dystonia\n* Cognitive problems that impede measurements\n* Severe co-morbidities\n* Peripheral spastic medication","healthyVolunteers":true,"sex":"ALL","minimumAge":"18 Years","maximumAge":"100 Years","stdAges":["ADULT","OLDER_ADULT"],"studyPopulation":"Adults with first ever chronic stroke:\n\n= First ever stroke subjects with established spasticity and without spasticity will be recruited on the stroke rehabilitation unit and outpatient rehabilitation clinic, University Hospital of Leuven.\n\nHealthy control subjects\n\n= Healthy age-and gender matched subjects will be recruited among healthy university staff of the University Hospital of Leuven, their family and friends.","samplingMethod":"NON_PROBABILITY_SAMPLE"},"contactsLocationsModule":{"centralContacts":[{"name":"Fabienne Schillebeeckx, MD","role":"CONTACT","phone":"0032 16 33 87 14","email":"fabienne.schillebeeckx@uzleuven.be"}],"overallOfficials":[{"name":"Fabienne Schillebeeckx, MD","affiliation":"UZ Leuven","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"UZ Leuven","status":"RECRUITING","city":"Leuven","zip":"3000","country":"Belgium","contacts":[{"name":"Fabienne Schillebeeckx, MD","role":"CONTACT","email":"fabienne.schillebeeckx@uzleuven.be"}],"geoPoint":{"lat":50.87959,"lon":4.70093}}]},"ipdSharingStatementModule":{"ipdSharing":"UNDECIDED"}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Cerebrovascular Accident","relevance":"HIGH"},{"id":"M11775","name":"Muscle Spasticity","relevance":"LOW"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"T1303","name":"Chronic Graft Versus Host Disease","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC05","name":"Musculoskeletal Diseases"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"Rare","name":"Rare Diseases"}]}},"hasResults":false}